Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes

Journal of the CardioMetabolic Syndrome

Volumn 4, Issue 1, 2009, Pages 50-56

  Krishnan, Sowmya ^a,b   Short, Kevin R ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LIPID; LIPOPROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; DISEASE COURSE; DRUG EFFICACY; EARLY DIAGNOSIS; GLYCEMIC CONTROL; HEALTH SURVEY; HEART DISEASE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; METABOLIC SYNDROME X; MICROANGIOPATHY; MORTALITY; NONHUMAN; OBESITY; ONSET AGE; PATIENT COUNSELING; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 61449252478     PISSN: 15594564     EISSN: 15594572     Source Type: Journal    
DOI: 10.1111/j.1559-4572.2008.00034.x     Document Type: Review

References (49)

1. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16:466-471.
2. Libby P, Nathan DM, Abraham K, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111:3489-3493.
3. Kavey R-EW, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2006;114:2710-2738.
4. Schwab KO, Doerfer J, Hecker W, et al. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care. 2006;29:218-225.
5. Katzmarzyk PT, Srinivasan SR, Wei C, et al. Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics. 2004;114:e198-e205.
6. McGill HC Jr, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712-2718.
7. Nathan DM, Lachin J, Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348:2294-2303.
8. Distiller LA, Joffe BI, Melville V, et al. Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus. J Diabetes Complicat. 2006;20:280-284.
9. Haller MJ, Samyn M, Nichols WW, et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care. 2004;27:2911-2917.
10. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005;111:747-753.
11. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation. 1997;96:1432-1437.
12. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26:386-391.
13. Krantz JS, Mack WJ, Hodis HN, et al. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr. 2004;145:452-457.
14. Jarvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes. 2002;51:493-498.
15. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 2003;41:661-665.
16. Ronnback M, Fagerudd J, Forsblom C, et al. Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004;110:1076-1082.
17. Shield JP, Hunt LP, Karachaliou F, et al. Is microalbuminuria progressive? Arch Dis Child. 1995;73:512-514.
18. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care. 1999;22:495-502.
19. Albanna II, Eichelberger SM, Khoury PR, et al. Diastolic dysfunction in young patients with insulin-dependent diabetes mellitus as determined by automated border detection. J Am Soc Echocardiogr. 1998;11:349-355.
20. Schannwell CM, Schneppenheim M, Perings S, et al. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002;98:33-39.
21. Suys BE, Katier N, Rooman RPA, et al. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care. 2004;27:1947-1953.
22. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974;34:29-34.
23. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980;99:446-458.
24. Jaffe AS, Spadaro JJ, Schechtman K, et al. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J. 1984;108:31-37.
25. Perez A, Wagner AM, Carreras G, et al. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: Effect of glycemic control. Arch Intern Med. 2000;160:2756-2762.
26. Kershnar AK, Daniels SR, Imperatore G, et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The search for diabetes in youth study. J Pediatr. 2006;149:314-319.
27. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care. 2003;26:2194-2197.
28. Torres-Tamayo M, Zamora-Gonzalez J, Bravo-Rios LE, et al. Lipoprotein a levels in children and adolescent with diabetes. Rev Invest Clin. 1997;49:437-443.
29. Klein RL, McHenry MB, Lok KH, et al. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: Associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complicat. 2005;19:18-25.
30. Labudovic DD, Toseska KN, Alabakovska SB, et al. Apolipoprotein a phenotypes and plasma lipoprotein a concentration in patients with diabetes mellitus. Clin Biochem. 2003;36:545-551.
31. Chaturvedi N, Fuller JH, Taskinen M-R. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care. 2001;24:2071-2077.
32. Jenkins A, Steele JS, JS S, et al. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes. 1991;40:787-790.
33. Stettler C, Suter Y, Allemann S, et al. Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: A 15-year follow up. J Intern Med. 2006;260:272-280.
34. Kanter JE, Johansson F, LeBoeuf RC, et al. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res. 2007;100:769-781.
35. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;30:977-986.
36. Wilkin TJ. The accelerator hypothesis: Weight gain as the missing link between type I and type II diabetes. Diabetologia. 2001;44:914-922.
37. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: A 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care. 2007;30:1248-1254.
38. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "Double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30:707-712.
39. Reinehr T, Holl RW, Roth CL, et al. Insulin resistance in children and adolescents with type 1 diabetes mellitus: Relation to obesity. Pediatr Diabetes. 2005;6:5-12.
40. Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association. Diabetes Care. 2005;28:186-212.
41. Microalbuminuria Collaborative Study Group UK. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br Med J. 1993;306:1235-1239.
42. Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes. 1994;43:1248-1253.
43. Lengyal Z, Rosivall L, Nemeth C, et al. Diurnal blood pressure pattern may predict the increase of urinary albumin excretion in normotensive normoalbuminuric type 1 diabetes mellitus patients. Diabetes Res Clin Pract. 2003;62:159-167.
44. Schram MT, Chaturvedi N, Fuller JH, et al. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: The EURODIAB prospective complications study. J Hypertens. 2003;21:2035-2044.
45. Shankar A, Klein R, Klein BEK, et al. Relationship between low-normal blood pressure and kidney disease in type 1 diabetes. Hypertension. 2007;49:48-54.
46. Koivisto VA, Stevens LK, Mattock M, et al. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care. 1996;19:689-697.
47. Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in insulin dependent diabetes: 10year observational follow up study. Br Med J. 1996;313:779-784.
48. Torffvit O, Lovestam-Adrian M, Agardh E, et al. Nephropathy, but not retinopathy, is associated with the development of heart disease in type 1 diabetes: A 12-year observation study of 462 patients. Diabet Med. 2005;22:723-729.
49. Sibal L, Law HN, Gebbie J, et al. Predicting the development of macrovascular disease in people with type 1 diabetes. A 9-Year Follow-up Study. Ann N Y Acad Sci. 2006;1084:191-207.